Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Researchers' work from University of Helsinki focuses on breast cancer
July 31st, 2008
New research, 'Tumor dormancy: elevated expression of stanniocalcins in late relapsing breast cancer,' is the subject of a report. According to a study from Helsinki, Finland, "Breast cancer is known for its propensity to recur even after decades. The biology behind this phenomenon of tumor dormancy is poorly understood." "The stanniocalcins (stanniocalcin-1, STC-1 and stanniocalcin-2, STC-2) are 56kDa homodimeric proteins. They act as pro-survival factors and contribute to the endurance of terminally differentiated cells such as neurons and adipocytes. We investigated whether elevated expression of stanniocalcins also plays a part in the tumor dormancy of breast...
Source: Women's Health Weekly (2008-07-31)
|
